NAS:MIST (Canada)  
Milestone Pharmaceuticals Inc logo

Milestone Pharmaceuticals Inc

$ 4.51 -0.24 (-5.05%) 10:08 PM EST
P/E:
At Loss
P/B:
1.78
Market Cap:
$ 154.63M
Enterprise V:
$ 88.20M
Volume:
262.18K
Avg Vol (2M):
863.41K
Volume:
262.18K
Market Cap $:
154.63M
PE Ratio:
At Loss
Avg Vol (2-Month):
863.41K
Enterprise Value $:
88.20M
PB Ratio:
1.78
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT.
Name Current Vs Industry Vs History
Cash-To-Debt 29.95
Equity-to-Asset 0.9
Debt-to-Equity 0.03
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.94
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -0.7
3-Year EPS without NRI Growth Rate -1.3
3-Year FCF Growth Rate 3.7
Name Current Vs Industry Vs History
5-Day RSI 22.86
9-Day RSI 33.97
14-Day RSI 36.34
6-1 Month Momentum % -14.72
12-1 Month Momentum % -15.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.71
Quick Ratio 12.71
Cash Ratio 11.84

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.9

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -4186.73
Net Margin % -4139.67
ROE % -61.53
ROA % -57.87
ROIC % -2284.84
ROC (Joel Greenblatt) % -4619.76
ROCE % -61.75

Financials (Next Earnings Date:2023-03-24 Est.)

MIST's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:MIST

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.5
EPS (TTM) ($) -1.46
Beta 2.13
Volatility % 75.73
14-Day RSI 36.34
14-Day ATR ($) 0.376321
20-Day SMA ($) 4.6765
12-1 Month Momentum % -15.78
52-Week Range ($) 3.9801 - 9.8465
Shares Outstanding (Mil) 34.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Milestone Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Milestone Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.